Details For Selected Brain Tumor Treatment

Sponsored By

Cedars-Siani Medical Center Brain Tumor Program

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme

		Phase:		Phase 3

		Treatment ID#:		1873

		Age Group:		Adults Only

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Prior Surgery is Not Allowed Prior Radiation is Not Allowed Prior Chemotherapy is Not Allowed

		Last Updated:		03/04/2009

		Tumor Types:		Glioblastoma Multiforme


		Comments:

		Treatment Type:		Surgery Chemotherapy Radiation Immunological, Biological or Targeted Therapy

		Contact:		Frank D. Vrionis MD, PhD Team Leader, Skull Base and Spinal Oncology H. Lee Moffitt Cancer Center and Research Institute 12902 Magnolia Drive, Suite 3136 Tampa, FL 33612 USA Phone: (813) 615-4251 Fax: E-mail: entissa@moffitt.usf.edu Website: www.moffitt.usf.edu/clinical/skull/index.htm

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By